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Abstract. With advances in genomic sequencing technology, a large amount of 
data is publicly available for the research community to extract meaningful and 
reliable associations among risk genes and the mechanisms of disease. However, 
this exponential growth of data is spread in over thousand heterogeneous 
repositories, represented in multiple formats and with different levels of quality 
what hinders the differentiation of clinically valid relationships from those that 
are less well-sustained and that could lead to wrong diagnosis. This paper 
presents how conceptual models can play a key role to efficiently manage 
genomic data. These data must be accessible, informative and reliable enough to 
extract valuable knowledge in the context of the identification of evidence 
supporting the relationship between DNA variants and disease. The approach 
presented in this paper provides a solution that help researchers to organize, store 
and process information focusing only on the data that is relevant and minimizing 
the impact that the information overload has in clinical and research contexts. A 
case-study (epilepsy) is also presented, to demonstrate its application in a real 
context.  
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Summary key points 
● A huge amount of genomic data is publicly available for the research 
community to extract meaningful and reliable knowledge, while Genomic data 
generation is growing exponentially. 
● Genomic data is heterogeneous, disperse, present a wide range of levels of 
quality and lacks ontological commitment. These hinders the application of 
genomic diagnosis into clinical practice. 
● The use of conceptual models is essential to deal with complexity in terms of 
understanding and communication of relevant data. We present a systematic 
framework -conceptual model-based- to efficiently manage genomic data to 
improve the efficiency and reliability of genomic diagnosis. 
● This framework uses a Conceptual Schema of the Human Genome to give 
structure and context to the data and it is supported by a data quality 
methodology specially designed for genomic information management. 
● The framework proved to increase the efficiency and reliability to determine 






During the last decades, technological advances in the field of genomics have allowed 
techniques like Next Generation Sequencing (NGS) [1] to become a routine research 
tool, improving our understanding on how inherited genetic differences among 
individuals (DNA variants) are involved in the risk of suffering a disease or present a 
particular trait. However, the volume of available information that these techniques 
produce increases in a faster pace than the ability of researchers to connect and analyze 
it.  
The lack of a clear ontological basis to define the key concepts and the continuous 
evolution of the domain knowledge generate too frequently a different and (potentially) 
ambiguous representation for common concepts [2,3]. Furthermore, all the knowledge 
is spread in over thousand heterogeneous databases with different sizes, formats and 
structures. The information may also contain errors caused by the complexity of the 
biological processes, the noisy nature of experimental data and the diversity of 
sequencing technologies, that results in a great variability in the quality of the available 
information [4,5]. These challenges hinder the progress of sound and correct 
approaches such as Precision Medicine (PM) [6], which aim is to provide an accurate 
prevention, diagnosis and treatment of human diseases considering the genetic 
variability, the environment and the lifestyle of each person. 
If we want to integrate the different perspectives of genomic data, a holistic view 
must be provided to facilitate the management of all those different genome 
dimensions, that go from the structural genotype to the functional phenotype. It is at 
this point that the use of Conceptual Modeling (CM) techniques helps to improve the 
understanding and the adequate communication of relevant data [7]. Therefore, the 
development of specific and correct conceptual model-based Information Systems (IS) 
gains significance. These IS allow: 
i. The connection of different “-omic” fields (Genomics, Proteomics, 
Pharmacogenomics, etc.) under a common and structured perspective,  
ii. The support of efficient management of genomic data that ought to be 
accessible, informative and actionable enough to infer valuable knowledge, 
and  
iii. The use of appropriate tools to analyze the data and generate new knowledge 
[8].  
On this basis, the design of a proper IS requires in the first place a sound ontological 
structure to represent and connect the heterogeneous elements of the domain [9,10]. 
Secondly, the system must support the efficient data management by defining a 
systematic process, from the selection of the appropriate data sources and the 
identification of relevant data, to their final load and exploitation to extract valuable 
knowledge. Finally, considering that the reliability of the results is highly dependent on 
the quality of the managed information, the IS must count with mechanisms to ensure 
that the results obtained during the process are of enough quality. 
In this paper, we present a framework based on a Conceptual Schema of the Human 
Genome (CSHG) to manage genomic data in an efficient way with the aim of 
developing and populating an IS with high quality data. The framework is supported 
by a data quality methodology specially designed for genomic information. The quality 
of the managed information is ensured by the selection of high-quality repositories, 
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extracting the highest quality information from each one and guaranteeing that the 
results derived from its analysis can be regarded as reliable and accurate. This approach 
can be applied to different parts of the biological domain; in this work we describe its 
application in the context of the identification of relevant genetic and experimental 
evidence supporting the relationship between DNA variants and disease. Given a 
particular phenotype, a well-known current problem is the identification of those 
variants that are relevant for the considered phenotype. This problem is especially 
important in diagnosis clinical contexts. The framework explained in the paper provides 
a sound and methodologically well-grounded solution.  
The paper is structured as follows. Section 2 presents the relevant research in the 
domain regarding the use of conceptual models and data quality, and the need of having 
specific solutions for the genomic domain. Section 3 describes the proposed framework 
using the concepts and methods that are previously introduced. Along Section 4 the 
application of the framework is presented using a case study that ends with a discussion 
about the results that are obtained.  Section 5 concludes the paper and proposes future 
research directions. 
2 Conceptual Modeling and Data Quality in Genomics 
Understanding the genome is probably the most complex scientific human challenge, 
and the complexity of the associated data is overwhelming. To face it, two main aspects 
must be considered: i) the use of conceptual models for the understanding of complex 
domains and ii) the use of data quality techniques to evaluate the accuracy, reliability 
and usefulness of the data to obtain meaningful conclusions from their analysis. These 
aspects provide a solid background to explore effective solutions. Nevertheless, the 
domain of Genomics has evolved so fast that these techniques must be adapted in order 
to extract all the potential benefits that the underlying knowledge has for the 
understanding, prevention and improvement of human health. In the next sections we 
analyze how both a sound conceptual model and a data quality methodology for 
genomics help to find out more adequate solutions.  
 
 
2.1 A Conceptual Model for Genomics 
The understanding of complex systems requires the integration of genomic data under 
well-constructed conceptual structures to describe the relationships between their 
components. However, the integration of different genomic databases is often 
challenging because they differ not only in the scope of the information they represent, 
but also in the way the same information is modeled. This situation hinders the process 
of retrieval, annotation and integration of heterogeneous datasets and consequently the 
quality of the conclusions derived from their analysis.  
We want to emphasize that most of the existing solutions work at the “solution 
space” instead of working at the “problem space”. By working at the solution space, 
we mean that they focus on representing data as they are used in practice, instead of 
focusing on the problem space, that faces the conceptual representation of the relevant 
domain concepts. Working at the solution space makes extremely hard to link data 
whose provenance is diverse, that use different formats and whose semantics is too 
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often too imprecise. In this context, well-known solutions have been proposed by the 
scientific community. One of these solutions is the construction of ontologies. 
Examples of such ontologies are:  
● Gene Ontology [11] describes the knowledge of the biological domain with 
respect to three aspects, i) molecular-level activities performed by gene 
products (molecular function), ii) the locations relative to cellular structures in 
which a gene product performs a function (cellular component) and iii) the 
larger processes accomplished by multiple molecular activities (biological 
process). 
● Sequence Ontology [12] describes the features and attributes of biological 
sequences that are defined by their disposition to be involved in a biological 
process. There are also experimental features which are the result of an 
experiment. 
● Genotype Ontology [13] represents the levels of genetic variation specified in 
genotypes. 
● Variation Ontology [14] describes the effects, consequences and mechanisms 
of variations on DNA, RNA and/or protein level 
● Phenotype ontology [15] describes phenotypic abnormalities encountered in 
human disease by providing an ontology of medically relevant phenotypes, 
disease-phenotype annotations, and the algorithms that operate on these. 
 
There are around 244 biomedical ontologies, with over 5,700,000 terms and 27,000 
properties according to the Ontology Lookup Service1. These ontologies are essentially 
large terminological resources that describe the terms used in the domain and the 
connections between these terms. But the use of all these domain ontologies in practice 
becomes a big problem. If we are interested in managing the particular data that one 
ontology describes (what we call a “vertical” data query dimension), everything can 
work reasonably well. But if we are interested in establishing valuable semantic 
connections among data provided not only by one ontology, but by many of them (what 
we refer to as an “horizontal” data query dimension), we have a problem. Imagine that 
we want to know the reason why a specific change in the genome (a DNA variant) 
produces the clinical manifestations of a disease. To solve this task it is required to 
navigate through the different concepts that connect the chromosomal elements affected 
by the variant (the transcripts, the genes, the proteins…), the functions that these 
elements perform (transcription regulation, ion transport, protein degradation…), the 
biological processes and reactions where these functions are involved (immunological 
response, transport of elements through the cellular components such as the plasmatic 
membrane, the normal growth of tissues,..) and the consequences of the malfunction of 
these processes that can be translated into the observable manifestations of a disease 
(recurrent infections, malabsorption, growth retardation, etc.). Navigating through all 
those different concepts to understand the precise semantic connection between 
genotype and phenotype requires to access many different data sources, each one 
normally specialized in a partial genomic dimension. 
To solve the problem, the holistic perspective that only a global conceptual model 




paper. A conceptual schema of the human genome is acting as a kind of conceptual 
database, that provides an unified perspective of all the relevant data that are in practice 
spread through a set of different data sources (data ontologies, databases, or however 
their creators call them). 
The use of conceptual models proves to be a powerful tool for the understanding and 
communication of complex domains by making a clear definition of the entities 
involved and the relationships among them. The idea of applying conceptual modeling 
to understand the genome has been explored by some authors within which we can 
highlight:  
I. The work presented by Chen et al. facilitated an Object-Protocol Model 
(OPM) [16] intending to bring an example of a combination of protocol and 
object constructions in a framework for the genomic domain, to provide 
modeling of objects and experiments (protocol).  
II. The DNA Databank of Japan (DDBJ2) used conceptual modeling to design 
and develop a new version of their Nucleotide Sequence Databank to facilitate 
a rapid change and growth according to their system requirements [17].  
III. The work presented in [18] introduces a cooperative computing environment 
(called “Imagenetrade mark”) dedicated to the analysis and annotation of 
genomic sequences, which has been developed by applying an object-based 
model. 
IV. The work presented by Paton [19] was focused on describing the genome from 
different perspectives, including the description of the eukaryotic cell genome, 
the interaction between proteins, the transcriptome and other genetic 
components, however, their work did not have a fruitful continuation in the 
domain. 
V. In [20], the principles of conceptual modeling were applied in the context of 
3D protein structures, which includes the consultation of large amounts of data 
and a very complex structure. 
 
But these approaches still focus on specific parts of the domain, they are unconnected 
from each other and do not provide the required global view to understand complex 
biological systems. New attempts to provide a sound, CM-based solution is being 
proposed recently. For instance, in the work presented by Bernasconi et al., a 
conceptual model of genomic metadata is proposed, whose purpose is to consult the 
underlying data sources to locate relevant experimental data sets [21]. Our work 
reinforces these approaches by using the Conceptual Schema of the Human Genome 
(CSHG) [22], developed in a previous work. The CSHG fills the gap providing a unified 
conceptual perspective to the partial ones that each of the above-mentioned solutions 
(ontologies and partial conceptual models) provide. Next, we explain in more detail the 
process that led to the development of a stable version of the CSHG. 
Considering that the conceptual background of the genomic domain is under a 
constant evolution, it is important to highlight that to reach this holistic representation 
of the human genome, different versions of the model were generated, through a 
process where the ontological foundations of the relevant concepts were under 
continuous discussion. This was strongly required to facilitate the understanding and 
 
2 The DNA Data Bank of Japan 
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allowed to extend and integrate all the new concepts according to the evolution of the 
domain and the well-grounded knowledge. Below is a brief detail of each of the 
generated versions of the CSHG, that have made possible to reach a stable state: 
● CSHG version 1: It is characterized by being the first attempt to address the 
holistic description of the genomic domain, and as such it uses a vision of the 
genome that is focused on its most basic concepts, ignoring some more 
complex aspects. CSHG version 1 focuses on the analysis of individual genes, 
their mutations, and their phenotypic aspects. In the modeling stages, four 
iterations were developed to reach the final version 1 of the CSHG (which can 
be consulted in [23]). This first version was classified into three main views: 
a) Gene-Mutation View; b) Genome View; and c) Transcription View [24] 
● CSHG version 1.1: It is the natural evolution of CSHG version 1. This 
comprises the inclusion of the phenotypic view in the model. The "phenotypic" 
vision is very important because it provides consistency to the model. The fact 
of offering a “genotypic” vision (genetic information that an organism has), 
linked to a “phenotypic” vision (expression of genotype depending on a certain 
environment), offers a significant research value and it increases the semantic 
completeness of the model. As the introduction of the phenotype dimension 
did not change the essential semantics of the CM, a release change was 
considered enough. 
● CSHG version 2: This version changes its central nucleus and goes from 
representing a "genecentristic" vision to a vision centered on the concept of 
"chromosome". This is why a version change was performed. Any relevant 
part of the genome is easily characterized as a particular chromosome part. 
This structural change of vision in the model represents the main difference 
concerning the previous versions of the model (v1 and v1.1). The full 
development phases that led to this evolution of the conceptual scheme can be 
consulted in detail in [22]. We decided to organize it in five mains “views” 
(see for instance [22]): 
○ Structural: it describes the genome structure. 
○ Transcription: it shows the components and concepts related to 
protein synthesis. 
○ Variation: it describes the changes in the sequence of reference. 
○ Pathways: it describes information about metabolic pathways. 
○ Bibliography and data bank: it describes the sources of relevant data.  
 
Currently, this stable version (CSHG version 2) of the model is being applied in 
practice, while continuous evaluation is in progress in order to be ready to generate any 
updated version that could better suit the needs of the domain. One of the practical cases 
of application of the model consists of studies on haplotypes and population genetics 
(which includes the integration of statistical -biological- patterns) resulting in the 
research work reported in [25].  
Without renouncing at all to the holistic purpose of the CSHG, in practical terms we 
need to focus on a particular dimension of interest. Analyzing all the conceptual 
connections that are represented in the whole model is not possible in one paper. To 
make the problem treatable, we will focus on this work only on the Variation view data, 




2.2 A Data Quality Methodology for Genomics 
Once the conceptual structure is clear, the next step is to define a process to ensure that 
the information managed has enough quality to be used in the clinical practice. The 
information to be managed is complex because i) data sources can contain errors, and 
ii) these errors can be propagated to other data sources that use the original one, 
increasing the noise and the efforts required for their analysis [26].  
The data quality connection is immediate. Even though data quality has been studied 
for decades, research on the quality of genomic data has just started and there are not 
sound results yet [27]. Most of the problems to face can be grouped into the assessment 
of six main categories or dimensions [4]:  
● Accessibility issues: even though most of the data stored in the genomic 
repositories are publicly available, there are some issues that can hinder the 
access, such as the lack of mechanisms to automatically query and download 
the results of a search.  
● Completeness issues: due to the extensive and ever-growing amount of 
available data, the process of manually marking specific features in a DNA 
sequence with descriptive information about its structure or its function is a 
time-consuming task. Therefore, some tools for automated processing and 
analysis of text are being developed to assist researchers in evaluating the 
scientific literature [28]. Although these tools speed up the annotation process, 
the heterogeneous nature of written resources and the difficulties of extracting 
knowledge embedded in free text (inconsistent gene nomenclature, domain-
specific languages and restricted access to full text articles,...) mean that the 
information annotated with these tools can contain missing values, affecting 
the completeness of the databases. 
● Consistency issues: genomic databases are very diverse, making extremely 
laborious to perform even simple queries across databases. As there is no 
standard format for genome data storage and no universally accepted 
vocabulary, consistency problems are especially significant when dealing with 
the terminology used to represent biological concepts. An example of these 
consistency problems is the classification of the type of DNA variants, which 
number ranges from 8 types (according to the HGVS3 recommendations) to 
31 (according to the ClinVar4 database). 
● Currency issues: as the underlying concepts are imperfectly defined, and 
scientific understanding of them is changing over time, the annotation of most 
genomes becomes outdated. There are also databases that do not have the 
required technological maintenance or do not review the information stored so 
they become obsolete too quickly. Consequently, most genome annotations 






● Redundancy issues: the lack of a precise ontological commitment tends to 
increase the redundancy in the collected data. The same entity can be 
submitted by different research groups to a database with different names, 
multiple times, or to different databases without a traceable cross-reference 
[30]. A high level of redundancy leads to an increase in the amount of data to 
be processed internally by the database and externally by the users. It also 
hinders the annotation process creating confusion and requiring additional 
time and effort to resolve missing, duplicate or inconsistent fields. 
● Reliability issues: all the above-mentioned problems decrease the reliability of 
the stored information. To minimize these issues, some databases are 
supported by external experts that manually review the information and 
correct the errors found. Nevertheless, this is a laborious process that, together 
with the lack of well-constructed information systems, explains why the use 
of these repositories is not an extended practice yet, hindering the exploitation 
of the full potential that these databases can offer. 
 
To address these problems and assure the veracity and value of the information, a 
Data Quality Methodology (DQM) must be defined. A DQM consists in a set of 
guidelines and techniques to define specific metrics in order to get a quantitative 
measure that represents the quality of the data. The methodology is divided into four 
main phases:  
● Dimension description: the interesting dimensions to be measured are 
described together with their scope. For example, to determine the quality of 
a genomic repository, one of the dimensions to be measured can be Currency. 
● Metric description: it describes the metrics associated to each dimension. For 
example, the currency of a database can be measured by its last update 
● Requirements description: its objective is to define the minimum levels of 
quality that must be fulfilled by assigning concrete acceptance criteria to each 
metric. For example, the requirement for the last update metric is less than one 
year, which means that a database must have been updated less than one year 
ago. 
● Data Quality Assessment: Once the dimensions, metrics and minimum 
requirements are established, a sound data quality assessment can be made by 
comparing the collected information and the minimum acceptance criteria that 
have been defined in the previous phase. For example, if the selected database 
has been updated less than one year ago, it can be considered as current. 
 
These phases are mostly application-dependent so they can be adapted to any 
possible given scenario. Using the artifacts resulting from each phase, the quality 
assessment can be performed allowing the selection of the data that accomplish the 
levels of quality established by the user. 
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3 A Framework for the Efficient Management of Genomic 
Information 
The framework presented in this paper uses the CSHG and the DQM described in the 
previous section and provides support to the four main tasks required to develop and 
populate an IS with relevant data:  
● The selection of the most adequate and reliable data repositories.  
● The identification and management of the relevant information. 
● The transformation of the subsequent data into a queryable format using the 
adequate technology, making them persistent. 
● The analysis and extraction of the underlying knowledge.  
 
The schema of the framework (see Fig. 1) is divided into three sections that represent 
the main concepts that have been explained along this work. At the top of the figure, 
the different stages that conform the data quality methodology are represented 
(Dimension Description, Metric Description, Requirements Description and Data 
Quality Assessment). At the bottom of the figure, the ontological support is defined as 
i) a Conceptualization Process that must be carried out to precisely define the concepts 
of the domain, and ii) a formalization of this conceptualization that results in the 
conceptual model. Finally, at the center of the figure, the four main sequential tasks that 
must be performed to populate an IS with relevant data can be found (Repository 
Selection, Information Identification, Information Persistence and Knowledge 
Extraction). The data quality methodology and the ontological support interact with the 
three first tasks providing a set of input elements:   
● The CSHG is the core of the ontological support and provides a unified 
structure to the information that comes from the different repositories. A set 
of mapping and transformation rules help to consistently represent the external 
data according to the structure defined by the CSHG. It also provides the 
association and constraint rules required to define the structure of the target 
database that will store the information. This process requires a 
conceptualization of the relevant information and its precise representation 
using the appropriate languages such as the diagrams provided by the Unified 
Modeling Language (UML, https://www.uml.org/). 
● The DQM supports the process of data repository selection and relevant data 
identification by providing the different sets of quality criteria to be applied 
on each stage.  
 
Finally, once the information is appropriately stored, a set of tools can be used to 
analyze and visualize the data in order to extract valuable knowledge. 
In the next section, we are going to present the application of the framework in the 
context of a case study: the systematic identification of relevant genetic and 
experimental evidence supporting the relationship between DNA variants and epilepsy. 
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4 Presentation of the Framework through a Case Study 
In order to explain the application of the framework, this section is structured as 
follows: first we explain how to prepare the conceptual and technological support to 
build the IS that will support the process (Section 4.1 to 4.4) and then we describe its 
execution to extract the required results (Section 4.5). These results have been 
positively validated by a group of experts in genetic diagnosis.  
 
 
4.1 Defining the Ontological Structure 
As it has been explained in previous sections, the key to build a sound IS is to ground 
it on a solid ontological commitment. In this example, we are focusing on solving a 
concrete task -the identification of relevant variants that are clinically related to the 
phenotype under study (epilepsy)-. This task requires to manage data about a specific 
part of the genomic domain. Using the holistic perspective provided by the CSHG as a 
basis, we can determine the parts of the model that provide the required structure to the 
data that is going to be managed. The resulting conceptual schema can be seen in Fig. 
2. 
The main entities of the conceptual schema are Variation and Gene. The Variation 
entity represents the changes in the DNA that are the cause of the Phenotype (disease) 
of interest. There are different types of variants, depending on i) the frequency of 
appearance in a certain Population (Mutant, Polymorphism, CNV and SNP) and ii) the 
precision of the information associated to them. If the location of the variant is known 
it is classified as Insertion, Deletion, Indel or Inversion. If the location of the variant is 
unknown, it is classified as Imprecise. 
The Gene entity represents the elements whose alteration derives in a malfunction 
that leads to the development of the disease. As the traceability of the data must be 
ensured, the schema also considers the information associated to the databases where 
the genomic data have been extracted from, represented by the classes 




4.2 Selecting Relevant Sources 
Once the conceptual schema is specified, the next step is the selection of the most 
adequate data sources to populate it. This process is based on the application of a set of 
data quality criteria in order to reduce the noise produced by the great number of 
publicly accessible repositories (over 1,500 according to a report of 2019 Molecular 
Biology Database Collection in the journal Nucleic Acids Research [31]). The selection 
of the adequate repositories is based on a set of quality criteria that considers the 
assessment of 3 dimensions and 5 metrics with their corresponding criteria of 
acceptance (see Table 1). 
In addition, the transformation and integration processes require following a 
sequence of steps:  
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● Data Processing: it involves cleaning the extracted data as well as 
converting all the values to the required data types. 
● Data Transformation: this step refers to the implementation of the 
transformation rules required to represent the information coming from the 
different repositories into a common structure. 
● Data Integration: it consolidates the data under a single unified view. 
● Data Deduplication: this step involves removing duplicate copies of 
repeating data. 
 
After this process, the data is prepared to be filtered with the aim of reducing the 
noise and the negative consequences of analyzing low quality data. 
 
 
4.3 Identifying the Relevant Information 
As not all the information coming from the repositories is reliable enough to perform a 
genetic diagnosis, it is important to measure its quality in order to ensure that only the 
most reliable one is considered. To this aim we have defined and implemented a set of 
quality criteria in agreement with the group of experts in genetic diagnosis that will 
validate the results of the process. These criteria are summarized in Table 2. 
We are aware of the complexity of the domain. Due to this complexity, the definition 
of the quality criteria can be adapted to any context of application by changing the 
default values or defining new criteria. At the end of the process, only the information 
that conforms the established criteria can be prepared to be stored adequately ensuring 
its persistency. 
 
4.4 Information Persistence and Knowledge Extraction 
With the aim of preparing the information for its further exploitation, it must be stored 
in a target database that conforms the structure provided by the CSHG. The selection 
of the adequate technology depends on the volume of the information to be managed 
as well as the further data analysis requirements. In addition, the process of providing 
persistency to the information requires to carry out the needed checks to provide strong 
data typing as well as referential integrity to ensure the accuracy and consistency of the 
data. In our case, we built a relational database because it is a well-known and widely 
accepted technology, with a solid technological background, and it provides an intuitive 
organization based on the table structure that is familiar to most users and close to the 
way the concepts are represented in the CSHG. It also adapts well to the type of queries 
that the problem requires, facilitating an effective data exploitation. These 
characteristics simplify the development and use of the database. In addition, data 
integrity is an essential feature of the relational databases. They provide strong data 
typing and validity checks as well as referential integrity, which ensure the accuracy 
and consistency of the data. Nevertheless, we are aware that other technologies such as 
NoSQL databases could be useful too, but on this case a SQL database fully complies 
with our requirements. 
The final aim of this approach is to extract knowledge from the information stored 
in the database through the use of analytical and graphic tools specifically designed for 
this domain. In our case, we use the information to provide support to the identification 
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of potentially damaging variants in the DNA of a patient, represented in a VCF file (the 
most accepted file format to represent and managing variants). This is a very complex 
and time-consuming task that is mainly performed manually. A tool called 
“GenesLove.Me” [32] has been developed to provide support to this task. Using the 
high-quality information stored in our IS, the tool generates an automatic report with 
the DNA variants present in a patient's sample, what is a valuable help for the 
geneticists/clinicians that only have to validate the results. 
As a proof of concept, we explain in the next subsection the results obtained after 




We used the IS developed considering the previously explained framework to 
determine the relevant variants that are associated with a higher risk of suffering 
epilepsy. The selected sources to extract the data (according to the stablished quality 
criteria) have been PubMed5, NCBI Assembly6, GWAS Catalog7, ClinVar8, Ensembl9, 
dbSNP10, HGNC11, Entrez Gen12 and 1000 Genomes13. This selection provides a 
reliable coverage of the most relevant genome data sources that is to be considered in 
the analyzed working domain. Using the automated connectors implemented to access 
data from each source, an initial extraction allowed us to integrate data from 11,506 
variants, 1,509 genes and 844 articles [33, pp. 57-58].  
Without the support of an IS, this information must be integrated and analyzed 
manually, which is human-error prone and it implies a waste of time and human 
resources. After applying the criteria defined to identify relevant variants according to 
the requirements of the experts, only 32 variants were considered as relevant to perform 
a genetic diagnosis (see Table 3, that summarizes the most relevant results). Almost 
64% variants were discarded because they do not have a relevant clinical significance 
or associated bibliography to verify the assertion, and about 16% of the variants were 
discarded because the studies performed were not statistically relevant enough 
according to our criteria (presented in Table 2). This gives an idea of the importance of 
managing high-quality, accurate data in genomic contexts.  
The results were validated by a group of experts as clearly relevant, reducing the 














4.6 Final Remarks 
With the ever-increasing volume of information generated for curing or treating 
diseases and cancers, conceptual model-based technologies, tools, and techniques 
should play a critical role in turning data into actionable knowledge to meet unstated 
and unmet medical needs. This is the main objective of the work presented in this paper.  
The case study that has been introduced can be generalized to any phenotype for 
which precise genome data have been registered. This facilitates the jump from 
prototyping to real application of the framework, defining what a sound and validated 
workflow framework means and determining how to balance agility needs in the 
identification of relevant variants while compliance and consistency of requirements 
are preserved. What is more important, this approach provides a sound methodological 
background to deal with potential inconsistencies and uncertainties in 
definitions and meta-data across the multiple datasets that form the basis of the 
complex, big genomic data world. 
5 Conclusion and Future Work 
The management of genome data is a complex and time-consuming task that requires 
a great effort from the researchers if they do not have the support of a systematic process 
and a well-grounded IS. The lack of a consistent process and the usage of non-
standardized data result in sub-optimal identification of relevant (clinically speaking) 
variants and longer periods of time to obtain an accurate information. In this work, the 
non-standardized problem is prevented by using sound conceptual modeling 
background (introduced in Section 2.1), and a data quality methodology (presented in 
Section 2.2) to provide the required consistent process support.   
Through the conceptual framework, we have stated the importance of using 
conceptual models to reduce the bottleneck that researchers must face when managing 
inconsistent, heterogeneous, dispersed and unaffordable huge amounts of biological 
data in continuous growth. The Conceptual Schema of the Human Genome provides a 
solid ontological structure to the data coming from diverse and heterogeneous 
repositories.  
The data quality methodology ensures that the managed information has enough 
quality to support the genetic diagnosis in a clinical context. The application of the 
framework to determine the variants associated with the risk of suffering epilepsy has 
been proved to be useful in reducing the effort and time required to perform the entire 
process. The criteria applied in the case study were adapted to the needs of the experts 
that collaborated in the validation. Nevertheless, we are aware about the complexity of 
the domain and that the characteristics of each disease differ in which criteria must be 
considered and how they should be applied. To address these challenges, we are 
working on a continuous improvement of the CSHG to consider all the new knowledge 
that the community is generating day after day, such the role of haplotypes and 
pathways in the development of complex disease.  
Additionally, we are working on providing an implementation of specific guidelines 
for the classification of DNA variants such as the ones provided by the American 
College of Medical Genetics (ACMG) and the Association for Molecular Pathology 
(AMP) [34], and the evaluations and adaptations performed by research groups like 
15 
ClinGen [35]. At the same time, we are preparing new case studies to corroborate that 
the results can be considered as accurate in as many scenarios as possible. 
As a conclusion, the use of conceptual models and data quality techniques is the 
basis to build dynamic, scalable and efficient IS that could interoperate with other 
systems. It allows to efficiently manage all the data required to understand the complex 
mechanisms that conform the genomic domain, ensuring a global data structure (key 
for interoperability) and a high-quality data management environment (key for 
generating accurate and reliable knowledge). 
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